Any current/future new fundraising through debt or equity?

No explicit mention of new fundraising through debt or equity in the provided transcript. The company reported a significant reduction in net debt to INR775 crores, down 52% from last year, reflecting strong cash flow management. The company aims to be a net debt zero company by next year (FY27), barring any additional capex or special requirements. FY27 capex is expected to be in the range of INR400-500 crores, focused on modernization, automation, and debottlenecking, likely funded through internal accruals. Capital allocation is focused on disciplined use of cash, supported by a recent INR2

Any current/future capex/capital investment/strategic investment?

FY26 capex was INR472 crores, focused on productivity improvement, sustainability, and selective growth opportunities. FY27 capex is expected to be INR400-500 crores, mainly towards modernization, automation, and debottlenecking operations. USD 13 million approved for setting up a pillow manufacturing unit in Nevada, U.S., which partially commenced commercial production as of March 31, 2026. Investments continue in innovation, sustainability, and nearshore manufacturing. Focus on expanding manufacturing presence in the U.S. through Ohio and Nevada pillow facilities to support long-term growth

Future growth expectations in sales/revenue/volumes?

FY27 is expected to deliver double-digit growth in top-line revenue, signaling a strong recovery and scaling phase post-FY26 challenges. Domestic Indian market predicted to grow robustly at around 26% to 30%, driven by increased consumption and brand expansion. Global B2B segment anticipates double-digit growth, supported by the U.S. and expansion into U.K., Europe, and other FTA-driven markets. Sleep category (pillows) in the U.S. aims to nearly double revenue from $27.5 million to $60 million in FY27. Flooring business targets 30% growth next year, primarily from soft flooring and ex

Future growth expectations in earnings/operating earnings/profits/EPS?

ROCE expected to improve with growth around more than 15%, focusing on an asset-light model (Page 16). FY27 guided for double-digit revenue growth and EBITDA margins advancing into the teens, targeting teen EBITDA margin and growth (Pages 6, 12). Q4 FY26 showed signs of recovery with a 7.7% sequential revenue growth and 10.8% EBITDA margin up 313 bps sequentially (Page 6). Operating model stress-tested; focus on margin recovery led by operating leverage and mix improvement in FY27 (Page 3). U.S. B2B pillows business expected to nearly double from $27.5 million to $60 million in FY27, c

IN US

Sale is live|00:00:00left today

Welspun Living LtdQ1 FY26Textiles & Apparels

Welspun Living Ltd Q1 FY26 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹139P/E: 53.1Market Cap: ₹12.4K CrSector: Textiles & Apparels

Management growth scorecard

Revenue

Category 3

Margin

Category 1

Fundraise

N/A

Order

N/A

Capex

Yes

2 of 3 growth signals are positive.

Full analysis

Revenue guidance

Category 3

→FY27 is expected to deliver double-digit growth in top-line revenue, signaling a strong recovery and scaling phase post-FY26 challenges.
→Domestic Indian market predicted to grow robustly at around 26% to 30%, driven by increased consumption and brand expansion.
→Global B2B segment anticipates double-digit growth, supported by the U.S. and expansion into U.K., Europe, and other FTA-driven markets.
→Sleep category (pillows) in the U.S. aims to nearly double revenue from $27.5 million to $60 million in FY27.
→Flooring business targets 30% growth next year, primarily from soft flooring and expansion in regions like Australia, New Zealand, Middle East, U.K., and Europe.
→Innovation-driven premiumization contributes around 22% to revenue growth, enhancing value-added product sales.
→Medium-term aspiration to reach INR 15,000 crores revenue within 3 years, currently optimized capacity supports INR 11,500-12,000 crores.
→Overall volume recovery is measured and supported by tariff easing and improving macroeconomic conditions globally.

Margin guidance

Category 1

→ROCE expected to improve with growth around more than 15%, focusing on an asset-light model (Page 16).
→FY27 guided for double-digit revenue growth and EBITDA margins advancing into the teens, targeting teen EBITDA margin and growth (Pages 6, 12).
→Q4 FY26 showed signs of recovery with a 7.7% sequential revenue growth and 10.8% EBITDA margin up 313 bps sequentially (Page 6).
→Operating model stress-tested; focus on margin recovery led by operating leverage and mix improvement in FY27 (Page 3).
→U.S. B2B pillows business expected to nearly double from $27.5 million to $60 million in FY27, contributing to growth (Page 13).
→Domestic India market projected to grow 26-30% in FY27 adding to revenue growth (Page 14).
→Flooring segment with potential 30% growth in FY27, especially soft flooring (Pages 5, 15).
→Overall expecting improved utilization, operational discipline, and margin progression supporting profit growth (Pages 6, 8).

3 more insights locked — sign up free to unlock

Fundraise plans

→No explicit mention of new fundraising through debt or equity in the provided transcript.
→The company reported a significant reduction in net debt to INR775 crores, down 52% from last year, reflecting strong cash flow management.
→The company aims to be a net debt zero company by next year (FY27), barring any additional capex or special requirements.
→FY27 capex is expected to be in the range of INR400-500 crores, focused on modernization, automation, and debottlenecking, likely funded through internal accruals.
→Capital allocation is focused on disciplined use of cash, supported by a recent INR252 crore buyback from available cash.
→No plans stated for equity fundraising; focus appears to be on debt reduction and internal funding for growth and capex.

Order book

The transcript does not explicitly mention current or expected orderbook/pending orders details for Welspun Living Limited. However, some relevant points can be inferred regarding demand and growth outlook: - Utilization level was around 86% in FY26, with expectations to improve going forward, indicating healthy order flow. - Growth is expected to be double-digit globally in FY27 with India showing strong momentum at 26-30% growth. - U.S. business set to double from $27 million to $60 million in pillow segment next year. - FTAs in U.K. and Europe expected to create new growth opportunities. - Discussions with customers ongoing regarding tariffs and pricing amid raw material inflation, showing active order management. - No loss of customers despite tariff uncertainties and macro challenges. No precise value or quantitative figures on orderbook or pending orders are provided in the call transcript.

Capex plans

Yes

→FY26 capex was INR472 crores, focused on productivity improvement, sustainability, and selective growth opportunities.
→FY27 capex is expected to be INR400-500 crores, mainly towards modernization, automation, and debottlenecking operations.
→USD 13 million approved for setting up a pillow manufacturing unit in Nevada, U.S., which partially commenced commercial production as of March 31, 2026.
→Investments continue in innovation, sustainability, and nearshore manufacturing.
→Focus on expanding manufacturing presence in the U.S. through Ohio and Nevada pillow facilities to support long-term growth in the sleep solutions category.
→No concrete guidance on large M&A, but the company remains open to opportunities aligned with existing global brands and growth in various countries.

How does Welspun Living Ltd rank vs peers in Textiles & Apparels?

Pro feature

1Welspun Living Ltd

Rev 3Mar 1

See full Textiles & Apparels sector rankings

Want more stocks like Welspun Living Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio